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Abstract
The aim of this study was to identify the inci-
dence of metabolic syndrome and related diseas-
es in the Khisêdjê population living in the Xingu 
Indigenous Park, Mato Grosso State, Brazil, from 
1999-2000 to 2010-2011. The study included 78 
individuals aged ≥ 20 years. Data were analyzed 
using Student t test, linear regression, and Pois-
son regression. In 10 years of follow-up, cumu-
lative incidence rates were 37.5% for metabolic 
syndrome, 47.4% for hypetriglyceridemia, 38.9% 
for arterial hypertension, 32% for central obesity, 
30.4% for excess weight, 29.1% for hypercholes-
terolemia, 25% for low HDLc, 10.4% for high 
LDLc, and 2.9% for diabetes mellitus. Age proved 
to be a risk factor for incidence of hypertension, 
diabetes, and elevated LDLc, regardless of gen-
der; male gender was a protective factor against 
incidence of central obesity, independently of 
age. The study showed deterioration of most 
target health indicators and exposure of the 
Khisêdjê to high cardiometabolic risk. These re-
sults may be related to changes in traditional 
lifestyle.
Metabolic Syndrome X; Chronic Disease;  
Indigenous Peoples; Incidence
Resumo
O objetivo deste estudo foi identificar a incidên-
cia de síndrome metabólica e doenças associa-
das na população Khisêdjê, residente no Parque 
Indígena do Xingu, Mato Grosso, Brasil, ao lon-
go do período de 1999-2000 a 2010-2011. Foram 
incluídos 78 indivíduos com idades ≥ 20 anos. 
Os dados foram avaliados por meio do teste t de 
Student, regressão linear múltipla e regressão de 
Poisson. Em dez anos de seguimento verificou-se 
a incidência acumulada de 37,5% de síndrome 
metabólica, 47,4% de hipetrigliceridemia, 38,9% 
de hipertensão arterial, 32% de obesidade cen-
tral, 30,4% de excesso de peso, 29,1% de hiperco-
lesterolemia, 25% de baixo HDLc, 10,4% de ele-
vado LDLc e 2,9% de diabetes mellitus. A idade 
foi identificada como um fator de risco para in-
cidência de hipertensão arterial, diabetes melli-
tus e elevado LDLc, independentemente do sexo; 
ser do sexo masculino foi fator de proteção para 
incidência de obesidade central, não importan-
do a idade. Identificou-se deterioração de gran-
de parte dos indicadores de saúde avaliados, 
estando os Khisêdjê expostos a elevado risco car-
diometabólico. Esse resultado pode estar relacio-
nado a alterações no estilo de vida tradicional.
Síndrome X Metabólica; Doença Crônica;  
População Indígena; Incidência
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Introduction
The health profile of Brazilian indigenous peo-
ples has undergone important changes over 
the years. Alterations in the family and social 
economy and the incorporation of new eating 
habits and customs have predisposed to an in-
crease in chronic non-communicable diseases 
(CNCD), thereby deteriorating the health status 
and thus the quality of life of these populations 
1,2,3,4,5,6,7,8,9,10,11.
Metabolic syndrome is a CNCD that can be 
defined as the simultaneous presence of at least 
three altered metabolic parameters: central obe-
sity, glucose intolerance, arterial hypertension, 
hypertriglyceridemia, or low HDL cholesterol 12. 
Its clinical relevance is due to the fact that af-
fected individuals present 1.5 to 2.5 times the 
risk of death from all causes or from cardiovas-
cular diseases when compared to those without 
the syndrome 13,14. Although not essential for 
the diagnosis, other disease conditions such as 
generalized obesity, hyperuricemia, hypercho-
lesterolemia, and elevated LDLc are reported as 
associated or aggravating factors for metabolic 
syndrome.
Although the numerous health risks and 
problems resulting from metabolic syndrome 
are known, few related studies have been done in 
Brazilian indigenous peoples. The available pub-
lications report prevalence rates ranging from 
11% to 65% 7,8,10,11,15,16. Data on the incidence of 
this syndrome or its evolution over the years in 
a single indigenous people have not been found 
thus far.
Likewise, no information is available on the 
incidence of diseases related to metabolic syn-
drome in Brazilian indigenous peoples. It is only 
known that cases of excess weight and alterations 
in blood pressure, glucose tolerance, or serum 
lipid concentrations, which were all rare decades 
ago, now appear reported in the literature with 
similar or greater frequency when compared to 
rates observed in the non-indigenous Brazilian 
population 1,4,5,9,10,11,15,17,18,19,20.
Considering the high prevalence rates of 
CNCD reported in Brazilian indigenous peoples, 
the health problems resulting from these dis-
eases, especially from metabolic syndrome, and 
the scarcity of scientific data on this subject, the 
current study aimed to estimate the incidence 
of metabolic syndrome and associated diseases 
in the Khisêdjê population living on the Middle 
Xingu River (Xingu Indigenous Park) over ten 
years of follow-up.
Material and methods
This was a cohort-type epidemiological study 
based on two cross-sectional studies among 
the Khisêdjê people in the years 1999-2000 and 
2010-2011.
The Suyá, or Khisêdjê as they call themselves, 
are the only people of the Jê language that live 
in the Xingu Indigenous Park. According to the 
pattern in this linguistic family, their villages are 
arranged in a circular layout, with the “men’s 
house” in the center and the other huts facing to-
ward it. They are currently distributed in five vil-
lages: the largest, Ngôjwêre, and Ngôsokô, Rop-
tôtxi, Beira Rio, and Terra Indígena Wawi 21. The 
two stages of this study were done in the main 
village, Ngôjwêre.
In 1999-2000, 86 Khisêdjê individuals of both 
genders and 20 years or older were examined 
(91.5% of the total number of eligible individu-
als) 8, and of these, 78 (90.7%) were reevaluated 
in 2010-2011 and therefore included in this study. 
Among the subjects not examined in 2010-2011 
(n = 8), six were not located (possibly having 
changed villages) and two were absent at the 
time of the data collection.
The data collection routines used in 1999-
2000 have been published previously 8. Briefly, 
duplicate anthropometric data were obtained by 
properly trained professionals, and laboratory 
tests were performed after 10 hours of fasting. 
With the exception of blood glucose, which was 
measured by the capillary test, all the other tests 
were performed in venous blood samples.
In 2010-2011 the Khisêdjê were contacted and 
identified by the medical cards used by the health 
team from the Federal University of São Paulo 
(UNIFESP). A standard data collection form was 
used. Anthropometric measurements were taken 
according to procedures recommended by the 
World Health Organization (WHO). Body mass 
index (BMI) was calculated as weight (in kilo-
grams) divided by height (in meters) squared. Ex-
cess weight was defined as BMI ≥ 25.0 kg/m2 22. 
Central obesity was defined according to the cut-
off points set by the WHO (waist circumference ≥ 
80.0cm for women or ≥ 94.0cm for men) 23. These 
measurements were taken with a portable scale, 
Líder brand, model P200m (Líder Balanças, Ara-
çatuba, Brazil), with a capacity of 200kg and ac-
curate to 50g; a portable platform stadiometer, 
WCS brand (Cardiomed, Curitiba, Brazil), with a 
scale from 20 to 220 cm; and a flexible fiberglass 
tape measure (TBW, China) with a scale from 0 
to 150 cm.
Laboratory tests were taken in the morning 
after 12 hours of fasting. The biological material 
(blood) was collected, processed, and stored (in 
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a freezer at -20ºC) in the village until sending to 
São Paulo. Transportation was done over land in 
a portable freezer for transporting heat-sensitive 
material (model FCW 20 EK; Domestic Medi-
cal Systems, UK). Samples were analyzed by the 
Central Laboratory of the São Paulo Hospital.
Systolic and diastolic blood pressure ((SBP 
and DBP) were measured with an automatic 
arm-adjusted arterial blood pressure moni-
tor (model HEM 742-INT; OMRON Healthcare, 
China), after resting for 10 minutes in the sitting 
position. Three measurements were taken, and 
the final value was taken as the mean of the latter 
two measurements. Classification of individuals 
used the consensus definition of metabolic syn-
drome proposed by the International Diabetes 
Federation (IDF), American Heart Association 
(AHA), National Heart, Lung and Blood Institute 
(NHLBI), World Heart Federation (WHF), Inter-
national Atherosclerosis Society (IAS), and Inter-
national Association for Study of Obesity (IASO) 
in the year 2009 12. Hypertension was defined as 
SBP ≥ 130.0mmHg or DBP ≥ 85.0mmHg.
The capillary blood glucose test used Kit One 
Touch Ultra 2 (Johnson & Johnson, São Paulo, 
Brazil) and the same brand of lancets and strips. 
Collection followed the manufacturer’s recom-
mended procedures. Individual glucose toler-
ance classification used the guidelines of the 
American Diabetes Association 24, with the 
corrections proposed by the WHO for capillary 
blood glucose 25. Thus, fasting blood glucose ≥ 
100mg/dL and < 110mg/dL was classified as al-
tered fasting blood glucose and ≥ 110mg/dL as 
diabetes mellitus.
Total cholesterol, high-density lipoprotein 
(HDLc), and triglycerides were determined by 
the colorimetric enzymatic method (OLYMPUS 
AU 640; Tek Medical, London, UK). Low-density 
lipoprotein (LDLc) was measured according to 
the formula by Friedwald et al. 26. Presence of 
dyslipidemia was defined according to the values 
proposed by the National Cholesterol Education 
Program Expert Panel 27, i.e., total cholesterol > 
200mg/dL or triglycerides > 150mg/dL or LDLc 
> 130mg/dL or HDLc < 40mg/dL for men and < 
50mg/dL for women.
Determination of uric acid used the colori-
metric enzymatic method (OLYMPUS AU 640). 
Hyperuricemia was defined as serum uric acid 
> 6mg/dL for women and > 7mg/dL, for men 28.
Identification of metabolic syndrome used 
the consensus criteria proposed by various or-
ganizations in 2009. Diagnosis of the syndrome 
was defined as the presence of at least three of the 
following: increased waist circumference, elevat-
ed fasting blood glucose, arterial hypertension, 
reduced HDL, and hypertriglyceridemia; use of 
medication to treat the above-mentioned dis-
eases characterized their diagnosis 12. The cutoff 
points have already been reported.
Importantly, the data presented here and 
referring to 1999-2000 were obtained from the 
file used in a PhD thesis 8,29. In order to allow 
comparison of the results from 1999-2000 and 
2010-2011, the variables were reclassified. Thus, 
all the outcomes were classified using the same 
cutoffs in the two study phases (1999-2000 and 
2010-2011).
The data description used measures of cen-
tral tendency and dispersion for the quantita-
tive variables. Comparison of mean values for 
the biological variables in the same individuals 
used the Student t test for dependent (matched) 
pairs 30. Multiple linear regression was used to 
analyzed 11 distinct outcomes. Each model in-
cluded an outcome variable (anthropometric, 
physical, or laboratory) and two exposure vari-
ables [gender and age in 1999-2000, in years 
(continuous)]. Each outcome was measured by 
the following equation: value obtained in 2010-
2011 minus value obtained in 1999-2000, divided 
by value obtained in 1999-2000. This stage of the 
data analysis included all the individuals with or 
without the target outcomes in 1999-2000.
Cumulative incidence was calculated consid-
ering only the individuals without the nutritional 
condition or chronic disease in 1999-2000 and 
that were thus at risk of becoming cases over the 
10 years between the two evaluations. The study 
design did not allow calculating the incidence 
rates, due to the lack of information on person-
years of exposure.
Poisson regression with robust variance was 
used to analyze nine distinct outcomes (number 
of new cases). Each model consisted of an out-
come variable (nutritional condition or chronic 
disease) and two exposure variables [gender and 
age in 1999-2000, in years (continuous)]. This 
analysis only included individuals that did not 
present the target outcomes in 1999-2000. All 
stages of the analysis used Stata (Stata Corp., Col-
lege Station, USA).
The current study is part of a larger project 
entitled Nutritional and Metabolic Profile of the 
Khisêdjê Indigenous People, approved by the Bra-
zilian National Commission on Research Ethics 
(CONEP) and the Ethics Research Committee of 
UNIFESP (case review 760/10). In order to fur-
ther comply with ethical guidelines, this specific 
study was submitted to and approved by the 
Ethics Research Committee of UNIFESP (case re-
view 319/11).
In order to obtain approval by the Khisêdjê 
people, they were provided with an explanation 
of the study’s objectives and procedures. Indig-
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enous translators helped explain the study to the 
community in the native language. Signatures 
were collected simultaneously with a statement 
by the indigenous leaders who expressed their 
agreement with the study. Considering Reso-
lution 196/96 of the Brazilian National Health 
Council, item IV.3 line “e”, providing that “in 
culturally differentiated communities, includ-
ing indigenous peoples, advance agreement 
by the community should be obtained through 
their own leaders, but without ruling out ef-
forts to obtain individual consent,” and given 
the particular characteristics of these research 
subjects, whenever possible a free and informed 
consent form was obtained with signatures by 
the participants.
The study was funded by the São Paulo 
State Research Foundation (FAPESP; grant 
2010/52263-7).
Results
Of the 78 individuals included in the study, 36 
(46.2%) were females and 42 (53.8%) males. 
Mean age in 1999-2000 was 36.3 years (SD = 13.4). 
There was no significant age difference between 
the genders in either study phase.
Table 1 shows the mean values for the anthro-
pometric, physical, and laboratory variables for 
the Khisêdjê according to gender in both periods. 
Comparison of the mean values shows that in fe-
males, only arm circumference and DBP failed to 
show statistically significant alterations over the 
years; the increase in mean HDLc and decrease 
in LDLc can be considered beneficial. In males, 
only LDLc failed to show a significant change; the 
reduction in DBP and increase in HDLc can also 
be considered beneficial.
As shown in Table 2, for women the outcomes 
SBP (β = 0.0046mmHg; 95%CI: 0.0003; 0.0089), to-
tal cholesterol (β = 0.0073mg/dL; 95%CI: 0.0011; 
0.0136), HDLc (β = 0.0218mg/dL; 95%CI: 0.0143; 
0.0294), and LDLc (β = 0.0080mg/dL; 95%CI: 
0.0011; 0.0148) increased with age. In males, 
while BMI (β = -0.0019kg/m2; 95%CI: -0.0034; 
-0.0005) decreased with age (in years), SBP 
(β = 0.0083mmHg; 95%CI: 0.0043; 0.0123) and 
DBP (β = 0.0057mmHg; 95%CI: 00.0027; 0.0088) 
increased.
Table 3 shows the number of new cases of nu-
tritional conditions or chronic diseases over the 
course of 10 years. Females showed higher cumu-
lative incidence than males for metabolic syn-
drome (48.1% vs. 27.6%), central obesity (60% vs. 
20%), and elevated LDLc (19% vs. 3.7%). Mean-
while, males showed higher incidence than fe-
males for arterial hypertension (41.7% vs. 36.2%), 
hypercholesterolemia (33.3% vs. 24%), and hy-
peruricemia (21.9% vs. 5.9%).
Table 4 shows the incidence ratios for nutri-
tional conditions or chronic diseases, adjusted 
Table 1
Number of Khisêdjê indigenous individuals evaluated in 1999-2000 and in 2010-2011 and mean values for anthropometric, physical, and laboratory variables 
according to gender and year of data collection. Xingu Indigenous Park, Central Brazil, 2013.
Variables Females Males
n 1999-2000 2010-2011 p-value * n 1999-2000 2010-2011 p-value *
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
BMI (kg/m2) 35 23.1 (2.9) 24.3 (3.6) 0.0128 42 25.8 (2.9) 26.2 (3.7) 0.0389
Waist circumference (cm) 35 82.4 (7.1) 88.1 (8.9) 0.0001 41 84.8 (11.1) 90.7 (8.4) < 0.0001
Arm circumference (cm) 35 27.3 (2.5) 27.7 (3.3) 0.1927 42 29.0 (5.0) 30.7 (3.0) 0.0168
SBP (mmHg) 36 103.5 (9.3) 120.1 (18.9) < 0.0001 39 114.9 (11.2) 125.7 (17.1) 0.0019
DBP (mmHg) 36 65.7 (6.4) 67.8 (9.9) 0.1036 39 72.5 (6.5) 66.3 (8.7) 0.0006
Fasting blood glucose (mg/dL) 33 85.2 (7.8) 89.9 (10.4) 0.0125 36 85.1 (8.3) 92.4 (8.2) 0.0007
Total cholesterol (mg/dL) 34 176.7 (42.0) 189.2 (54.2) 0.0389 36 172.0 (31.5) 187.4 (28.3) 0.0003
HDLc (mg/dL) 34 34.3 (10.2) 43.9 (11.8) < 0.0001 36 25.6 (6.7) 39.4 (7.4) < 0.0001
LDLc (mg/dL) 32 122.7 (37.7) 111.0 (43.1) 0.0218 31 104.9 (29.2) 103.5 (22.5) 0.3525
Triglycerides (mg/dL) 34 122.1 (72.8) 188.4 (105.4) < 0.0001 36 192.3 (97.4) 242.3 (146.8) 0.0331
Uric acid (mg/dL) 34 3.8 (0.8) 4.5 (1.0) < 0.0001 36 5.8 (1.2) 6.5 (1.5) < 0.0001
SD: standard deviation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDLc: high-density lipoprotein; LDLc: low-density 
lipoprotein. 
* Matched Student t test.
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simultaneously for age (in years) and gender. 
Independently of gender, relative risk was 1.03 
(95%CI: 1.01; 1.05) for arterial hypertension, 1.04 
(95%CI: 1.01; 1.07) for diabetes mellitus, and 1.10 
(95%CI: 1.04; 1.17) for elevated LDLc. Meanwhile, 
the analysis in males identified a reduction in the 
incidence of central obesity (RR = 0.33; 95%CI: 
0.15; 0.72), independently of age. Due to the 
small number of new cases, low HDLc (n = 1) was 
excluded from the analysis.
Discussion
Ever since the Khisêdjê people first came to the 
Xingu Indigenous Park, they have maintained 
good relations with the neighboring towns and 
have thus intensified their contact with adjacent 
society. Over the years they have achieved impor-
tant victories such a population comeback, in-
fluenced by moderate birth rates, a drop in mor-
tality, and a negative migratory coefficient, but 
they have also been exposed to high CNCD rates, 
identified by cross-sectional studies in 1999-2000 
and 2010-2011 8,16,31,32.
The current study showed that in the ten 
years between the two evaluations, 21 (37.5%) 
new cases of metabolic syndrome occurred, and 
that incidence was higher in females, with a to-
tal of 13 (48.1%) new cases. Incidence of meta-
bolic syndrome was not significantly associated 
with gender or age. No studies have been identi-
fied thus far that have evaluated the incidence 
of metabolic syndrome in Brazilian indigenous 
peoples, to serve as a source of comparison.
Metabolic syndrome is an important CNCD 
which is related to increased risk of cardiovas-
cular diseases, diabetes mellitus, and all-cause 
mortality, among numerous other harms. Early 
detection thus allows the possibility of treatment 
and consequently a reduction in health problems 
12,14,25,27,33,34,35,36,37,38,39.
Mean BMI values increased in both genders 
over the course of ten years (Table 1), but mean 
BMI in females remained below that found in 
the 1st National Health and Nutritional Survey of 
Brazilian Indigenous Peoples, a study that used 
a probabilistic sample of women 14 to 49 years 
of age and children under 60 months, living in 
villages in four major geographic regions of the 
country (BMI = 25.2kg/m2; 95%CI: 24.7; 25.8) 40. 
When adjusted for age, in males there was a re-
duction in BMI with age, that is, older individu-
als showed lower mean body mass index. These 
results may be related to older males’ non-adher-
ence to the new living and eating habits that have 
occurred in the villages, or to the aging process 
itself. The 1st National Health and Nutritional 
Survey of Brazilian Indigenous Peoples showed 
the opposite in women, an increase in BMI with 
age; however, the age range in the sample was 
lower than in the current study 40.
Table 2
β coefficient for age (linear regression) and 95% confidence interval (95%CI) for anthropometric, physical, and laboratory variables (independent models for 
each variable) in Khisêdjê indigenous individuals evaluated in 1999-2000 and 2010-2011, according to gender. Xingu Indigenous Park, Central Brazil, 2013.
Variables Females * Males *
Age coefficient (years) 95%CI Age coefficient (years) 95%CI
BMI (kg/m2) ** -0.0019 -0.0053; 0.0015 -0.0019 -0.0034; -0.0005
Waist circumference (cm) ** -0.0007 -0.0035; 0.0019 -0.0032 -0.0069; 0.0005
Arm circumference (cm) ** -0.0010 -0.0038; 0.0018 -0.0029 -0.0146; 0.0088
SBP (mmHg) ** 0.0046 0.0003; 0.0089 0.0083 0.0043; 0.0123
DBP (mmHg) ** -0.0019 -0.0055; 0.0017 0.0057 0.0027; 0.0088
Fasting blood glucose (mg/dL) ** 0.0013 -0.0022; 0.0047 0.0001 -0.0044; 0.0045
Total cholesterol (mg/dL) ** 0.0073 0.0011; 0.0136 -0.0023 -0.0064; 0.0018
HDLc (mg/dL) ** 0.0218 0.0143; 0.0294 0.0014 -0.0066; 0.0095
LDLc (mg/dL) ** 0.0080 0.0011; 0.0148 -0.0006 -0.0065; 0.0053
Triglycerides (mg/dL) ** -0.0154 -0.0394; 0.0086 -0.0319 -0.0683; 0.0045
Uric acid (mg/dL) ** 0.0052 -0.0015; 0.0118 -0.0011 -0.0057; 0.0035
SD: standard deviation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDLc: high-density lipoprotein; LDLc: low-density 
lipoprotein. 
* Multiple linear regression adjusted for age in years (continuous) in 1999-2000, according to gender; 
** (value for variable in 2010-2011 – value for variable in 1999-2000)/value for variable in 1999-2000.
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Table 3
Number and percentage of Khisêdjê indigenous individuals evaluated in 1999-2000 and 2010-2011 according to occurrence 
of new cases of altered metabolic or nutritional profile during the period, according to gender. Xingu Indigenous Park, Central 
Brazil, 2013.
Variables/Categories Females Males p-value * Total
n % n % n %
Metabolic syndrome 0.112
No 14 51.9 21 72.4 35 62.5
Yes 13 48.1 8 27.6 21 37.5
Excess weight 0.887
No 19 70.4 13 68.4 32 69.6
Yes 8 29.6 6 31.6 14 30.4
Central obesity 0.005
No 6 40.0 28 80.0 34 68.0
Yes 9 60.0 7 20.0 16 32.0
Arterial hypertension 0.629
No 23 63.9 21 58.3 44 61.1
Yes 13 36.2 15 41.7 28 38.9
Diabetes mellitus 0.950
No 32 97.0 35 97.2 67 97.1
Yes 1 3.0 1 2.8 2 2.9
Hypercholesterolemia 0.448
No 19 76.0 20 66.7 39 70.9
Yes 6 24.0 10 33.3 16 29.1
Low HDLc 0.505
No 2 66.7 1 100 3 75.0
Yes 1 33.3 - - 1 25.0
High LDLc 0.084
No 17 81.0 26 96.3 43 89.6
Yes 4 19.0 1 3.7 5 10.4
Hypertriglyceridemia 0.914
No 13 52.0 7 53.8 20 52.6
Yes 12 48.0 6 46.2 18 47.4
Hyperuricemia 0.058
No 32 94.1 25 78.1 57 86.4
Yes 2 5.9 7 21.9 9 13.6
HDLc: high-density lipoprotein; LDLc: low-density lipoprotein. 
* Refers to χ2 test.
As identified with the excess weight vari-
able, cumulative incidence of central obesity 
in the Khisêdjê was around 30%, and was even 
more alarming in women (60%). The protection 
against incidence of central obesity in males (RR = 
0.33), independently of age, highlights the rel-
evance of this outcome, which is associated with 
increased risk of cardiovascular diseases and oth-
er CNCD 22 for females. An important hypothesis 
(but not investigated in the current study) is the 
high number of pregnancies among indigenous 
women over the course of their childbearing 
years. Data from the National Demographic and 
Health Survey of Brazilian Women and Children 
in 2006 showed that the highest prevalence rates 
of elevated waist circumference occurred pre-
cisely in women with the most children 41. An-
other relevant limiting factor relates to the diag-
nostic criteria used to identify nutritional status 
and some metabolic conditions, which may not 
be appropriate for indigenous individuals.
Among the other target components, the 
study identified an increase in SBP in both 
genders and DBP in males, with increasing age 
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(Table 2). These data contrast with the informa-
tion published in 1988 by the Intersalt Study, 
which showed that in a sample of indigenous 
individuals from the Xingu (N = 198) there was 
only a minor increase in SBP (0.6mmHg) and 
a decrease in DBP (0.4mmHg) with increasing 
age 41,42. However, they partially corroborate the 
findings from the 1st National Health and Nutri-
tional Survey of Brazilian Indigenous Peoples 40 
showing that SBP, and DBP in females, increased 
statistically with age. Similar to the current study, 
another study among indigenous people from 
the Suruí ethnic group in the State of Rondônia, 
Brazil, showed a minor increase in mean SBP and 
DBP in both genders between 1988 and 2005, 
which only reached statistical significance for 
SBP in females 44. Hypertension was the second 
most frequent incident disease (39.8%) over the 
ten years of follow-up, and there was an increase 
of 3% for each year of life, independently of gen-
der. These results may relate to changes in eating 
habits and lifestyle among the population. Mean 
SBP and DBP levels in the Khisêdjê, especially in 
2010-2011, were higher than those observed in 
indigenous peoples of the Xingu as reported in 
the Intersalt Study 42,43.
Despite the low cumulative incidence (2.9%) 
of diabetes mellitus over the ten years, these re-
sults are higher than the findings by Baruzzi 3, 
who reported that as of 2002 only two cases of 
diabetes had been identified in the Xingu Indig-
enous Park, both in women from other ethnic 
groups. On the other hand, these findings are low-
er than those reported by other authors reporting 
high incidence rates for diabetes mellitus (> 17%) 
among different indigenous peoples around the 
world. Obesity, family history of diabetes, and ge-
netic and environmental factors are related to the 
etiology of this disease 34,45,46,47,48,49,50,51. A study 
of North American indigenous peoples from 13 
different ethnic groups showed lower diabetes 
incidence among participants who reported 
any type of physical activity when compared to 
physically inactive individuals 49. Based on these 
findings, the low incidence of diabetes found in 
the current study may be explained by the same 
factor, since recent data show that the Khisêdjê 
are physically active and in good shape 16,52.
Low HDLc is considered a strong indepen-
dent predictor of coronary disease 27. Among 
the Khisêdjê this was the most frequent condi-
tion both in 1999-2000 (88.9%) and in 2010-2011 
(66.2%) 8,16. In the current study, only one new 
case of low HDLc was identified in ten years. 
However, this incidence cannot be considered 
low, since it may been due to the fact that prev-
alence of the condition was already high at the 
beginning of the study, that is, few individuals 
(n = 4) were at risk of becoming new cases. A 
study in 2010 found that low HDLc may be re-
lated to genetic alterations in the metabolism of 
Native American peoples as a form of adaptive 
response to the environment 53.
Although high LDLc was not the main lipid 
disorder found in the Khisêdjê in 1999-2000 or 
2010-2011, the increase in its levels with increas-
Table 4
Cumulative incidence ratios (CIR) by point and 95% confidence intervals (95%CI), adjusted simultaneously according to  
gender and age, for alterations in metabolic and nutritional profile in Khisêdjê indigenous individuals evaluated in  
1999-2000 and 2010-2011. Xingu Indigenous Park, Central Brazil, 2013.
Variables (new cases of) CIR * 95%CI CIR * 95%CI
Age (in years) ** Gender (male vs. female) **
Metabolic syndrome 1.01 0.98; 1.03 0.57 0.28; 1.16 
Excess weight 0.98 0.94; 1.01 0.96 0.41; 2.25
Central obesity 0.99 0.96; 1.02 0.33 0.15; 0.72
Arterial hypertension 1.03 1.01; 1.05 1.19 0.68; 2.07
Diabetes mellitus 1.04 1.01; 1.07 0.99 0.07; 15.02
Hypercholesterolemia 1.02 0.99; 1.05 1.37 0.58; 3.21
High LDLc 1.10 1.04; 1.17 0.18 0.02; 1.89
Hypertriglyceridemia 0.98 0.95; 1.01 1.03 0.52; 2.06
Hyperuricemia 1.04 0.99; 1.08 3.84 0.99; 14.95
* Robust Poisson regression adjusted simultaneously for age and gender; 
** Reference: younger age (in years, collected in 1999-2000); 
*** Reference: female gender.  
HDLc: high-density lipoprotein; LDLc: low-density lipoprotein.
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ing age emphasize the need for surveillance of 
this and other cardiovascular risk factors among 
these individuals. Likewise, the high cumulative 
incidence of hypertriglyceridemia (47.4%) and 
high prevalence rates in this population expose 
the individuals to high cardiovascular and meta-
bolic risks.
In general, the adoption of non-traditional 
foods, changes in patterns of physical activity 
and customs (such as the use of new technolo-
gies) and the increase in the family economy 
based especially on paid work and social position 
(socioeconomic status) are factors commonly re-
lated to the appearance of metabolic syndrome 
and other CNCD among indigenous and non-
indigenous peoples 1,3,4,5,6,7,9,10,11,18,20,32,54,55,56,57.
The study’s potential limitations include the 
possible variation (under or overestimation) of 
cumulative incidence rates resulting from loss of 
follow-up of eight indigenous individuals from 
the beginning of the study (9.3% of total eligible 
subjects). As an example, if the eight individuals 
had become cases of metabolic syndrome, the 
cumulative incidence would have been 45.3% 
(95%CI: 32.8; 57.8), but if they had remained 
free of the syndrome, the incidence would have 
been 32.8% (95%CI: 21.0; 44.6), while the figure 
found in the study was 37.5% (95%CI: 24.4; 50.6). 
Meanwhile, the exclusion of cases of diabetes 
mellitus identified in 2010-2011 via the oral glu-
cose tolerance test and the fact that the test was 
not performed in 1999-2000 may have contrib-
uted to underestimation of the observed diabe-
tes incidence.
The current study showed deterioration in 
many of the target health indicators. The high 
cumulative incidence rates for metabolic syn-
drome, hypertriglyceridemia, hypertension, cen-
tral obesity, and excess weight among the Khisêd-
jê are alarming and predispose them to high risk 
of cardiovascular diseases. Although these results 
are not necessarily representative for identifica-
tion of the deterioration of health indicators for 
all Brazilian indigenous peoples, they raise an 
alert concerning the need to implement effective 
interventions to protect these peoples from the 
acculturation that has encroached unfortunately 
on their daily lives over the years.
Resumen
El objetivo del estudio fue identificar la incidencia del 
síndrome metabólico y de enfermedades asociadas en 
la población Khisêdjê, que reside en el Reserva Indíge-
na de Xingú, Mato Grosso, Brasil, durante los años de 
1999-2000 a 2010-2011. Fueron incluidos 78 individuos 
con edad ≥ 20 años. Los datos fueron evaluados a tra-
vés de las pruebas estadísticas t de Student, regresión 
lineal múltiple y regresión de Poisson. La incidencia 
acumulada en los 10 años de seguimiento fue de 37,5% 
de síndrome metabólico, 47,4% de hipertrigliceridemia, 
38,9% de hipertensión arterial y 32% de obesidad cen-
tral. Independientemente del sexo, la edad está relacio-
nada como factor de riesgo para la incidencia de hiper-
tensión arterial, diabetes mellitus, y LDLc elevado. Ser 
de sexo masculino se constituye en un factor de protec-
ción para la incidencia de obesidad central, indepen-
dientemente de la edad. Fueron identificados deterioros 
significativos en gran parte de los indicadores de salud 
evaluados en los Khisêdjê expuestos a riesgo cardiome-
tabólico elevado. Este resultado puede estar relaciona-
do con la alteración del estilo de vida tradicional de la 
población estudiada.
Síndrome X Metabólico; Enfermedad Crónica;  
Población Indígena; Incidencia
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